2003
Management of dyslipidemias in the age of statins
Green ML. Management of dyslipidemias in the age of statins. Primary Care Clinics In Office Practice 2003, 30: 641-669. PMID: 15024890, DOI: 10.1016/s0095-4543(03)00095-2.Peer-Reviewed Original ResearchConceptsOverall CHD riskLipid-lowering therapyLow HDL cholesterolCHD riskHDL cholesterolClinical trialsSmall dense LDL particlesLipid-lowering potencyLipid-lowering dietManagement of dyslipidemiaAppropriate lifestyle changesHigh LDL cholesterolHigh triglyceride levelsDense LDL particlesHigh-risk menRisk reductionIsolated hypertriglyceridemiaElevated lipoproteinPharmacologic therapyMetabolic syndromeLDL cholesterolPrimary preventionParticular medicationTriglyceride levelsPatient preferences
2002
Evaluation and Management of Dyslipidemia in Patients with HIV Infection
Green ML. Evaluation and Management of Dyslipidemia in Patients with HIV Infection. Journal Of General Internal Medicine 2002, 17: 797-810. PMID: 12390557, PMCID: PMC1495116, DOI: 10.1046/j.1525-1497.2002.20201.x.Peer-Reviewed Original ResearchConceptsHIV infectionMetabolic abnormalitiesAntiretroviral therapyLipid abnormalitiesInsulin resistanceSevere hypertriglyceridemiaMultiple potential drug interactionsLong-term cardiovascular riskLow-density lipoprotein cholesterolCoronary heart disease riskNon-nucleoside reverse transcriptase inhibitorFrank diabetes mellitusPI-naïve patientsActive antiretroviral therapyCD4 lymphocyte countHIV infection statusHIV viral loadLipid-lowering medicationsManagement of dyslipidemiaElevated total cholesterolHeart disease riskPotential drug interactionsTreatment of dyslipidemiaReverse transcriptase inhibitorSame metabolic abnormality